BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7504284)

  • 1. Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients.
    Su Y; Brooks DG; Li L; Lepercq J; Trofatter JA; Ravetch JV; Lebo RV
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10856-60. PubMed ID: 7504284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homomeric interactions of the MPZ Ig domain and their relation to Charcot-Marie-Tooth disease.
    Ptak CP; Peterson TA; Hopkins JB; Ahern CA; Shy ME; Piper RC
    Brain; 2023 Dec; 146(12):5110-5123. PubMed ID: 37542466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
    Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
    Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin protein zero mutation-related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohort.
    Bremer J; Meinhardt A; Katona I; Senderek J; Kämmerer-Gassler EK; Roos A; Ferbert A; Schröder JM; Nikolin S; Nolte K; Sellhaus B; Popzhelyazkova K; Tacke F; Schara-Schmidt U; Neuen-Jacob E; de Groote CC; de Jonghe P; Timmerman V; Baets J; Weis J
    Brain Pathol; 2024 Jan; 34(1):e13200. PubMed ID: 37581289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth Disease with Myelin Protein Zero Mutation Presenting as Painful, Predominant Small-Fiber Neuropathy.
    Gemignani F; Percesepe A; Gualandi F; Allegri I; Bellanova MF; Nuredini A; Saccani E; Ambrosini E; Barili V; Uliana V
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural bases for the Charcot-Marie-Tooth disease induced by single amino acid substitutions of myelin protein zero.
    Sakakura M; Tanabe M; Mori M; Takahashi H; Mio K
    Structure; 2023 Nov; 31(11):1452-1462.e4. PubMed ID: 37699394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B.
    Touvier T; Veneri FA; Claessens A; Ferri C; Mastrangelo R; Sorgiati N; Bianchi F; Valenzano S; Del Carro U; Rivellini C; Duong P; Shy ME; Kelly JW; Svaren J; Wiseman RL; D'Antonio M
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease.
    Pisciotta C; Pareyson D
    Neuromuscul Disord; 2023 Aug; 33(8):627-635. PubMed ID: 37455204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: A novel variant (H49N) in
    Cao GH; Zhao MF; Dong Y; Fan LL; Liu YH; Deng Y; Tang LL
    Front Neurol; 2024; 15():1319962. PubMed ID: 38481944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.
    Georgiou E; Kagiava A; Sargiannidou I; Schiza N; Stavrou M; Richter J; Tryfonos C; Heslegrave A; Zetterberg H; Christodoulou C; Kleopa KA
    Mol Ther; 2023 Nov; 31(11):3290-3307. PubMed ID: 37641403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Bilateral Vestibular Neuropathy in a Turkish CMT1B Family With a Novel
    Akdal G; Koçoğlu K; Bora E; Koç A; Ülgenalp A; Bedir M; Ala RT; Battaloğlu E; Kırkım G; Şengün İŞ; Halmágyi GM
    Neurol Clin Pract; 2021 Apr; 11(2):e129-e134. PubMed ID: 33842081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Sox10 and Egr2 in myelin gene regulation.
    Jones EA; Jang SW; Mager GM; Chang LW; Srinivasan R; Gokey NG; Ward RM; Nagarajan R; Svaren J
    Neuron Glia Biol; 2007 Nov; 3(4):377-87. PubMed ID: 18634568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrinsically disordered protein glue of the myelin major dense line: Linking AlphaFold2 predictions to experimental data.
    Krokengen OC; Raasakka A; Kursula P
    Biochem Biophys Rep; 2023 Jul; 34():101474. PubMed ID: 37153862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humans: the ultimate animal models.
    Reilly MM; Rossor AM
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1132-1136. PubMed ID: 32769113
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropathy-related mutations alter the membrane binding properties of the human myelin protein P0 cytoplasmic tail.
    Raasakka A; Ruskamo S; Barker R; Krokengen OC; Vatne GH; Kristiansen CK; Hallin EI; Skoda MWA; Bergmann U; Wacklin-Knecht H; Jones NC; Hoffmann SV; Kursula P
    PLoS One; 2019; 14(6):e0216833. PubMed ID: 31173589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPZL2, Encoding the Epithelial Junctional Protein Myelin Protein Zero-like 2, Is Essential for Hearing in Man and Mouse.
    Wesdorp M; Murillo-Cuesta S; Peters T; Celaya AM; Oonk A; Schraders M; Oostrik J; Gomez-Rosas E; Beynon AJ; Hartel BP; Okkersen K; Koenen HJPM; Weeda J; Lelieveld S; Voermans NC; Joosten I; Hoyng CB; Lichtner P; Kunst HPM; Feenstra I; de Bruijn SE; ; Admiraal RJC; Yntema HG; van Wijk E; Del Castillo I; Serra P; Varela-Nieto I; Pennings RJE; Kremer H
    Am J Hum Genet; 2018 Jul; 103(1):74-88. PubMed ID: 29961571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2.
    Fogarty EA; Brewer MH; Rodriguez-Molina JF; Law WD; Ma KH; Steinberg NM; Svaren J; Antonellis A
    Hum Mol Genet; 2016 Sep; 25(18):3925-3936. PubMed ID: 27466180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate signals through mGluR2 to control Schwann cell differentiation and proliferation.
    Saitoh F; Wakatsuki S; Tokunaga S; Fujieda H; Araki T
    Sci Rep; 2016 Jul; 6():29856. PubMed ID: 27432639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic recruitment of the curvature-sensitive protein ArhGAP44 to nanoscale membrane deformations limits exploratory filopodia initiation in neurons.
    Galic M; Tsai FC; Collins SR; Matis M; Bandara S; Meyer T
    Elife; 2014 Dec; 3():e03116. PubMed ID: 25498153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo.
    Antonellis A; Dennis MY; Burzynski G; Huynh J; Maduro V; Hodonsky CJ; Khajavi M; Szigeti K; Mukkamala S; Bessling SL; Pavan WJ; McCallion AS; Lupski JR; Green ED;
    PLoS One; 2010 Dec; 5(12):e14346. PubMed ID: 21179557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.